ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,071.63
      0.02%
      US Tech 100
      16,908.00
      -0.89%
      Dow Jones
      38,460.92
      -0.11%
      Brent Oil
      87.225
      0.01%
      Bitcoin
      63,457.48
      -1.28%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Amneal Pharmaceuticals Holding Co (AMRX)

      7. Amneal Pharmaceuticals Holding Co (AMRX) News

      AMRX Amneal Pharmaceuticals Holding Co

      5.87
      0.00 (0.00%)
      Pre Market
      Last Updated: 20:00:00
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Amneal Pharmaceuticals Holding Co AMRX NYSE Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 5.87 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      5.87
      more quote information »

      Recent News

      Date Time Source Heading
      4/24/202408:00BWAmneal Announces U.S. FDA Approval of Over-the-Counter..
      4/16/202408:00BWAmneal Launches PEMRYDI RTU®, the First Ready-to-Use Version..
      4/10/202408:00BWAmneal to Report First Quarter 2024 Results on May 3, 2024
      3/28/202416:05BWAmneal to Ring the Nasdaq Closing Bell on April 2, 2024
      3/25/202416:05BWAmneal Receives U.S. FDA Approval for Ciprofloxacin and..
      3/22/202408:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      3/22/202408:01EDGAR2Form DEF 14A - Other definitive proxy statements
      3/06/202417:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/06/202417:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202416:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202416:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/01/202406:13EDGAR2Form 8-K - Current report
      3/01/202406:00BWAmneal Reports Fourth Quarter and Full Year 2023 Financial..
      2/29/202416:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/27/202408:00BWAmneal Enters into Exclusive European Licensing Agreement..
      2/13/202408:00BWAmneal to Participate at Upcoming Investor Conference
      2/08/202416:05GLOBEAmneal Announces Complete Response Resubmission for IPX203..
      1/31/202416:05BWAmneal to Report Fourth Quarter and Full Year 2023 Results..
      1/10/202408:00BWAmneal Launches Complex Generic Fluorometholone Ophthalmic..
      1/04/202416:05BWAmneal Launched Record Number of 39 New Retail and..
      12/26/202316:10EDGAR2Form 25 - Notification of the removal from listing and..
      12/26/202316:05EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
      12/21/202308:00BWAmneal to Participate at the 42nd Annual J.P. Morgan..
      12/15/202316:15EDGAR2Form 8-K - Current report
      12/15/202316:06EDGAR2Form 8-K/A - Current report: [Amend]
      12/15/202316:05BWAmneal Announces Move to Nasdaq
      12/07/202308:00BWAmneal and BIAL Announce U.S. Licensing Agreement for..
      12/01/202316:15EDGAR2Form SC 13D/A - General statement of acquisition of..
      12/01/202316:15EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
      12/01/202308:00BWAmneal Expands Portfolio with Addition of Icosapent Ethyl..
      11/20/202306:07EDGAR2Form 15-12G - Securities registration termination [Section..
      11/08/202318:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/08/202318:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/08/202318:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/08/202318:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/08/202318:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/08/202317:15EDGAR2Form S-8 POS - Securities to be offered to employees in..
      11/08/202317:13EDGAR2Form POS AM - Post-Effective amendments for registration..
      11/08/202317:12EDGAR2Form POS AM - Post-Effective amendments for registration..
      11/08/202317:07EDGAR2Form SC 13D/A - General statement of acquisition of..
      11/08/202317:05EDGAR2Form SC 13D/A - General statement of acquisition of..
      11/08/202317:03EDGAR2Form SC 13D/A - General statement of acquisition of..
      11/08/202316:59EDGAR2Form SC 13D/A - General statement of acquisition of..
      11/08/202316:55EDGAR2Form SC 13D/A - General statement of acquisition of..
      11/08/202307:40EDGAR2Form 8-K12B - Notification that a class of securities of..
      11/07/202306:21EDGAR2Form 8-K - Current report
      11/07/202306:00BWAmneal Reports Third Quarter 2023 Financial Results
      11/03/202308:00BWAmneal to Participate at Upcoming Investor Conferences
      10/23/202316:16EDGAR2Form 8-K - Current report
      10/23/202316:05BWAmneal Reports Certain Preliminary Third Quarter 2023..

      Your Recent History

      NYSE
      AMRX
      Amneal Pharmaceuticals
      Delayed Upgrade Clock